[1] Bramhall SR, Neoptolemos JP, Stamp GW, et al. Imbalance of expression matrix metalloproteinase (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. J Pathol, 1997, 182:347-355. [2] 刘复生,刘彤华(主编).肿瘤病理学.北京医科大学中国协和大学出版社,1997 P1739-1776. [3] Garzetti GG, Giavattini A, Lucarini G, et al. Expression of vascular endothelial growth factor related to 72-kilodalton metalloproteinase immunostaining in patients with serous ovarian tumors. Cancer, 1999,85:2219-2225. [4] Yoshizaki T, Sato H, Murono S, et al. Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator. Clin Exp Metastasis, 1999,17:431-436. [5] Chenard MP, Lutz Y, Mechine-Neuville A, et al. Presence of high levels of MT-MMP protein in fibroblastic cells of human invasive carcinomas. Int J Cancer, 1999, 82:208-212. [6] Theret N, Musso O, L'Helgoualch A, et al. Differential expression and origin of membane-type 1 and 2 matrix metalloproteinases(MTMMPs) in association with MMP2 activation on injured human livers.Am J Pathol, 1998, 153:945-954. |